| Insulin Desk Reference |
| |
| Management of Diabetes is perhaps one of the most important and interesting subjects in clinical practice considering its high prevalence as well as the profound impact the treatment has on long term morbidity and mortality of the patient. In the Indian context, increasing urbanization, industrialization and changing lifestyles seem to be contributing to increasing prevalence of diabetes and recent studies have indicated the prevalence rate of 7% to 8% in urban population. Even a conservative estimate of 2%, points to a population of 1.6 crore diabetic, or potentially diabetic individuals in India. With increased awareness among the general public and improved facilities for diabetes detection, we are bound to observe a phenomenal increase in the number of diagnosed as well as treated diabetic patients in the coming decade. |
| |
| Current research indicates that ‘good metabolic control’ holds the promise of a better life for diabetic patients who are known to be more prone to complications. It is recognized that retinopathy is 25 times and nephropathy 17 times more common among diabetics as compared to the general population. |
| |
| The Diabetes Control and Complications Trial (D.C.C.T) which was one of the largest and the longest trial ever undertaken in the field of diabetes by National Institute of Health, U.S.A., has concluded that good metabolic control is the most important variable in the treatment of diabetes. The study conclusively demonstrated that tight control not only delays diabetic complications but possibly prevents them from occurring. The position statement released by the American Diabetic Association on D.C.C.T. is changing the focus of the treatment from mere ‘control’ to ‘good metabolic control’. |
| |
| The recent study in Type 2 diabetics; the Kumamoto study from Japan; has shown that good glycemic control can delay the onset or progression of microvascular complications like diabetic retinopathy, nephropathy and neuropathy. |
| |
| While diet, exercise and oral drugs are useful in controlling many patients, it is now recognized that a large number of Type II patients require insulin therapy due to oral drugs failing to provide good metabolic control and during special situations e.g. while undergoing surgery, during pregnancy, during chronic infections e.g. tuberculosis. In such circumstances insulin administration is the key to patients well being. Familiarity and comfort with insulins – both among medical practitioners and patients is essential for successful use of this life saving drug. |
| |
| Keeping this factor in mind, we are bringing ‘Insulin Desk Reference’ to medical practitioners. It is a handy reference book providing the latest and the most relevant pharmacotherapeutic information on insulins and specific details about Magnus Novo Nordisk Insulins. |
| |
| The Magnus Novo Nordisk Insulins range is the most complete and comprehensive international range available in India for your diabetic patients. It not only includes highly purified porcine and human monocomponent insulins but also the most sophisticated insulin delivery system such as the NovoPen 3 and insulin Penfills. |
| |
| For your convenience, we have given a summary of Magnus Novo Nordisk insulin brands to serve as a ready reckoner. |
| |
| We sincerely hope that this Insulin Desk reference will be useful to you and will be valuable addition to your collection of medical books. |
| |
|
